These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1676166)

  • 21. Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?
    Brooks S; Kaur S; Starr BS; Starr MS
    J Neural Transm (Vienna); 1996; 103(6):737-48. PubMed ID: 8836935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of central D1 dopamine receptors reverses reserpine-induced hypothermia in mice.
    Duterte-Boucher D; Panissaud C; Michael-Titus A; Costentin J
    Neuropharmacology; 1989 Apr; 28(4):419-21. PubMed ID: 2568597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
    Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):133-42. PubMed ID: 7710665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1995; 9(1):31-43. PubMed ID: 7605588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors.
    Merali Z; Piggins H
    Eur J Pharmacol; 1990 Dec; 191(3):281-93. PubMed ID: 2086245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243.
    Robertson HA; Peterson MR; Worth GG
    Brain Res; 1992 Oct; 593(2):332-4. PubMed ID: 1360321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice.
    Costentin J; Duterte-Boucher D; Panissaud C; Michael-Titus A
    Neuropharmacology; 1990 Jan; 29(1):31-5. PubMed ID: 1968237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
    Berry SA; Gudelsky GA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.
    Molloy AG; O'Boyle KM; Pugh MT; Waddington JL
    Pharmacol Biochem Behav; 1986 Jul; 25(1):249-53. PubMed ID: 3529126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
    Neisewander JL; Lucki I; McGonigle P
    J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.